Royalty Pharma

36.01
-0.13
-0.36%
RPRX
高 36.36开 36.32量 203.97万股总市值 210.00亿
低 35.95换 0.35%额 7354.89万市盈TTM 20.57
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
Royalty Pharma(RPRX)
10-01 04:55  
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683607-25-000004  Size: 4 KB 网页链接
用户头像
Royalty Pharma(RPRX)
09-17 04:15  
$Royalty Pharma(RPRX)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001193125-25-204983  Act: 34  Size: 773 KB 网页链接
用户头像
Royalty Pharma(RPRX)
09-04 04:55  
$Royalty Pharma(RPRX)$ 424B2 Prospectus [Rule 424(b)(2)] Accession Number: 0001193125-25-195026  Act: 33  Size: 832 KB 网页链接
用户头像
Royalty Pharma(RPRX)
09-03 18:05  
$Royalty Pharma(RPRX)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-25-194193  Act: 34  Size: 42 KB 网页链接
用户头像
Royalty Pharma(RPRX)
09-02 21:15  
$Royalty Pharma(RPRX)$ POSASR Post-effective Amendment to an automatic shelf registration statement Accession Number: 0001193125-25-193495  Act: 33  Size: 303 KB 网页链接
用户头像
Royalty Pharma(RPRX)
09-02 21:15  
$Royalty Pharma(RPRX)$ 424B2 Prospectus [Rule 424(b)(2)] Accession Number: 0001193125-25-193500  Act: 33  Size: 635 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-14 20:35  
$Royalty Pharma(RPRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000950142-25-002172  Act: 34  Size: 46 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-14 04:35  
$Royalty Pharma(RPRX)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-25-179892  Act: 34  Size: 154 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-14 00:55  
$Royalty Pharma(RPRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001562230-25-000094  Act: 34  Size: 7 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-12 04:45  
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-25-000107  Size: 9 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-12 04:25  
$Royalty Pharma(RPRX)$ 144 Report of proposed sale of securities Accession Number: 0001964306-25-000309  Act: 33  Size: 4 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-09 05:05  
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-25-000102  Size: 5 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-09 05:05  
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-25-000103  Size: 18 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-09 05:05  
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-25-000104  Size: 14 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-09 05:05  
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-25-000105  Size: 19 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-09 04:55  
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-25-000101  Size: 9 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-06 21:35  
$Royalty Pharma(RPRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001802768-25-000095  Act: 34  Size: 11 MB 网页链接
用户头像
Royalty Pharma(RPRX)
08-06 19:15  
$Royalty Pharma(RPRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-173988  Act: 34  Size: 376 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-06 00:05  
$Royalty Pharma(RPRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000895421-25-000451  Act: 34  Size: 11 KB 网页链接
用户头像
Royalty Pharma(RPRX)
08-01 08:55  
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001802768-25-000090  Size: 6 KB 网页链接